AAIC 2025 Abstract·26 DecExploration of an instrument measuring outcomes most important to patients through analysis of Overture dataTrial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecSpectris TM non‐invasive neuromodulation in Alzheimer’s diseaseTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecSpectris™ treatment is associated with significant time saved in the OVERTURE feasibility and open label extension (OLE) studyTrial in peopleInterventionsPaper